Sensitivity and specificity of ECG criteria in the diagnosis of left atrium enlargement in patients with arterial hypertension

封面

如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅或者付费存取

详细

Left atrium (LA) enlargement according to echocardiography (EchoCG) data is an early manifestation of organ damage in arterial hypertension (AH) and is a predictor of atrial fibrillation (AF).

The aim: to determine the sensitivity and specificity of electrocardiographic (ECG) criteria in the diagnosis of LA enlargement established by transthoracic echocardiography.

Material and methods. 40 patients with stage 1–2 arterial hypertension were examined: 25 patients with left atrial volume index (LAVI) ≥ 34 ml/m2 and 15 with LAVI ≤ 33.9 ml/m2. In addition to a general clinical examination, all patients underwent a comparative analysis of ECG and EchoCG parameters reflecting LA enlargement: LAVI, anteroposterior size, and LA length were assessed by EchoCG, while R wave duration, its shape, duration of the negative portion of R wave in lead V1 (RV1), and the Macruz index were assessed by ECG. The sensitivity and specificity of ECG signs in diagnosing LA enlargement established by echocardiography were determined using ROC analysis.

Results. In patients with arterial hypertension, the LA length was more often increased (77.5%) than its anteroposterior size (47.5%). The sensitivity of ECG signs of LA enlargement (R wave duration, its double hump, RV1 wave with a widened negative phase) did not always exceed 50%, but a number of ECG parameters were highly specific concerning both LA volume and linear dimensions.

Conclusion. The presence of RV1 wave with a wide negative phase is the most specific sign of an increase in both LA volume and its anteroposterior size and length. Highly specific signs of LA length enlargement include double hump of R wave, presence of RV1 wave with a widened negative phase and an increase of Macruz index.

全文:

受限制的访问

作者简介

Alexander Bursikov

Ivanovo State Medical University

编辑信件的主要联系方式.
Email: a.v.bursikov@mail.ru
ORCID iD: 0000-0002-9971-6468

MD, Dr. Sci. (Medicine), Associate Professor, Head of the Department of Internal Medicine Propaedeutics

俄罗斯联邦, 8, Sheremetevsky Ave., Ivanovo, 153012

Elena Abrashkina

Ivanovo State Medical University

Email: elenaabrashkina@mail.ru
ORCID iD: 0000-0002-6675-3641

MD, Dr. Sci. (Medicine), Associate Professor of the Department of Internal Medicine Propaedeutics

俄罗斯联邦, 8, Sheremetevsky Ave., Ivanovo, 153012

Marina Galkina

Ivanovo Veterans Hospital

Email: galkina-marina3@yandex.ru
ORCID iD: 0009-0008-1879-7640

MD, Doctor of Functional Diagnostics

俄罗斯联邦, 9, Demidov St., Ivanovo, 153002

参考

  1. Барсуков А.В. Гипертоническое сердце в терапевтической практике. СПб.: ЭЛБИ-СПб. 2016; 384 с. [Barsukov AV. Hypertensive heart in therapeutic practice. Saint Petersburg: ELBI-SPb. 2016; 384 pp. (In Russ.)]. ISBN: 978-5-91322-096-7.
  2. Verdecchia P, Reboldi GP, Gattobigio R, Bentivoglio M, Borgioni C, Angeli F et al. Atrial fibrillation in hypertension: Predictors and outcome. Hypertension. 2003;41:218–223. PMID: 12574085. https://doi.org/10.1161/01.hyp.0000052830.02773.e4
  3. ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of Hypertension: Endorsed by the International Society of Hypertension (ISH) and the European Renal Association (ERA). J Hypertens. 2023;41(12):1874–2071. PMID: 37345492. https://doi.org/10.1097/hjh.0000000000003480
  4. McEvoy JW, McCarthy CP, Bruno RM, Brouwers S, Canavan MD, Ceconi C et al.; ESC Scientific Document Group. 2024 ESC Guidelines for the management of elevated blood pressure and hypertension. Eur Heart J. 2024;45(38):3912–4018. PMID: 39210715. https://doi.org/10.1093/eurheartj/ehae178
  5. Abhayaratna WP, Seward JB, Appleton CP, Douglas PS, Oh JK, Tajik AJ, Tsang TSM. Left atrial size: Physiologic determinants and clinical applications. J Am Coll Cardiol. 2006;47(12):2357–63. PMID: 16781359. https://doi.org/10.1016/j.jacc.2006.02.048
  6. Medi C, Kalman JM, Spence SJ, Spence SJ, Teh AW, Lee G et al. Atrial electrical and structural changes associated with longstanding hypertension in humans: Implications for the substrate for atrial fibrillation. J Cardiovasc Electrophysiol. 2011;22(12):1317–24. PMID: 21736657. https://doi.org/10.1111/j.1540-8167.2011.02125.x
  7. Reyes JL, Norby FL, Ji Y, Wang W, Parikh R, Zhang MJ et al. Association of abnormal p-wave parameters with brain MRI morphology: The atherosclerosis risk in communities neurocognitive study (ARIC-NCS). Pacing Clin Electrophysiol. 2023;46(8):951–59. PMID: 36924350. PMCID: PMC10440299. https://doi.org/10.1111/pace.14687
  8. Platonov PG. P-wave morphology: Underlying mechanisms and clinical implications. Ann Noninvasive Electrocardiol. 2012;17(3):161–69. PMID: 22816534. PMCID: PMC6932587. https://doi.org/10.1111/j.1542-474x.2012.00534.x
  9. Chen LY, Ribeiro ALP, Platonov PG, Cygankiewicz I, Soliman EZ, Gorenek B et al. Wave parameters and indices: A critical appraisal of clinical utility, challenges, and future research – a consensus document endorsed by the International Society of Electrocardiology and the International Society for Holter and Noninvasive Electrocardiology. Circ Arrhythm Electrophysiol. 2022; 5(4):e010435. PMID: 35333097. PMCID: PMC9070127. https://doi.org/10.1161/circep.121.010435
  10. Функциональная диагностика: национальное руководство. Под ред. Н.Ф. Берестень, В.А. Сандрикова, С.Н. Федоровой. М.: ГЭОТАР-Медиа. 2019; 784 с. [Functional diagnostics: National guidelines. Edited by NF Beresten, VA Sandrikova, SN Fedorova. Moscow: GEOTAR-Media. 2019; 784 pp. (In Russ.)]. ISBN: 978-5-9704-4242-5.
  11. Lang RM, Badano LP, Mor-Avi V, Afilalo J, Armstrong A, Ernande L et al. Recommendations for cardiac chamber quantification by echocardiography in adults: An update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr. 2015;28(1):1–39. PMID: 25559473. https://doi.org/10.1016/j.echo.2014.10.003
  12. Truong QA, Charipar EM, Ptaszek LM, Taylor C, Fontes JD, Kriegel M et al. Usefulness of electrocardiographic parameters as compared with computed tomography measures of left atrial volume enlargement: From the ROMICAT trial. J Electrocardiol. 2011;44(2):257–64. PMID: 20537347. PMCID: PMC2937190. https://doi.org/10.1016/j.jelectrocard.2010.04.011
  13. Джишамбаев Э.Д., Хакимова С.И., Аманалиева Н.О., Крошкин Ю.А. Изменения предсердного комплекса на электрокардиограмме у больных с метаболическим синдромом, осложненным аритмиями сердца. Кардиоваскулярная терапия и профилактика. 2016;15(5):39–42. [Dzhishambaev ED, Khakimova SI, Amanalieva NO, Kroshkin YuA. Changes in the atrial complex on the electrocardiogram in patients with metabolic syndrome complicated by cardiac arrhythmias. Kardiovaskulyarnaya terapiya i profilaktika = Cardiovascular Therapy and Prevention. 2016;15(5):39–42 (In Russ.)]. EDN: WYJSGP. http://dx.doi.org/10.15829/1728-8800-2016-5-39-42
  14. Alexander B, Milden J, Hazim B, Haseeb S, Bayes-Genis A, Elosua R et al. New electrocardiographic score for the prediction of atrial fibrillation: The MVP ECG risk score (morphology-voltage-P-wave duration). Ann Noninvasive Electrocardiol. 2019;24(6):e12669. PMID: 31184409. PMCID: PMC6931412. https://doi.org/10.1111/anec.12669
  15. Кобалава Ж.Д., Конради А.О., Недогода С.В., Шляхто Е.В., Арутюнов Г.П., Баранова Е.И. с соавт. Артериальная гипертензия у взрослых. Клинические рекомендации 2024. Российский кардиологический журнал. 2024;29(9):230–329. [Kobalava ZhD, Konradi AO, Nedogoda SV, Shlyakhto EV, Arutyunov GP, Baranova EI et al. Arterial hypertension in adults. Clinical guidelines 2024. Rossiyskiy kardiologicheskiy zhurnal = Russian Journal of Cardiology. 2024;29(9):230–329 (In Russ.)]. EDN: GUEWLU. https://doi.org/10.15829/1560-4071-2024-6117

补充文件

附件文件
动作
1. JATS XML

版权所有 © Bionika Media, 2025